Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
HPV Vaccine (Gardasil) - National Monitoring Overview 07/19/2011
Notice type:
3rd Party Publications
Date:
19/07/2011
Background Information Or Related Documents:
This update provides an overview of the reports of suspected adverse reactions received by the IMB in association with
Gardasil
. It includes all reports received up to June 2011 and incorporates the first year of the HSE human papillomavirus (HPV) Schools Immunisation Programme.
Overview of National Monitoring Experience with Gardasil
For further information about
Gardasil
, including the product information,
visit the HPV School Immunisation
section of our website.
« Back
Date Printed: 16/05/2024